Lonafarnib (CAS 193275-84-2): A Pharmaceutical Intermediate Essential for Targeted Therapies
In the intricate world of pharmaceutical synthesis and drug development, high-quality intermediates are the bedrock of innovation. Lonafarnib, identified by CAS number 193275-84-2, is one such critical compound. Primarily known for its potent farnesyl transferase inhibitory activity, Lonafarnib also serves as a valuable pharmaceutical intermediate. As a premier manufacturer and supplier of fine chemicals in China, we provide researchers and developers with consistent access to this vital compound, enabling the advancement of targeted therapies.
The Role of Lonafarnib as a Pharmaceutical Intermediate
Lonafarnib's complex molecular structure and its specific biochemical activity make it an attractive starting point or intermediate in the synthesis of novel drug candidates. Its ability to inhibit farnesyl transferase, an enzyme crucial for protein prenylation, directly impacts cellular signaling pathways often dysregulated in diseases like cancer and progeria. Pharmaceutical researchers leverage Lonafarnib not only for its direct therapeutic potential but also as a building block or reference compound in the development of new chemical entities (NCEs) designed to target similar biological pathways. The demand for high-purity Lonafarnib as an intermediate stems from the need for precise molecular structures and predictable reactivity in multi-step synthesis processes.
Chemical Properties and Quality Assurance
Lonafarnib (C27H31Br2ClN4O2) is typically supplied as a white powder with a high purity, often exceeding 99%. These specifications are crucial for its function as a pharmaceutical intermediate, where even minor impurities can significantly affect reaction yields, product purity, and the efficacy or safety of the final drug product. Manufacturers like us adhere to stringent quality assurance protocols, employing analytical techniques such as HPLC and NMR to verify purity and identity. This rigorous quality control ensures that every batch of Lonafarnib we supply meets the exacting standards required for pharmaceutical R&D and potential scale-up.
Strategic Sourcing from a China Manufacturer
For organizations seeking to buy Lonafarnib or understand its market price, sourcing from established Chinese manufacturers offers distinct advantages. Our company, as a direct producer, can ensure a stable supply chain and competitive pricing. This is particularly beneficial for R&D budgets, allowing for greater flexibility in purchasing quantities, from small research batches to larger pilot-scale needs. When you inquire about Lonafarnib, clearly communicating your project's scope and requirements will help us provide the most relevant information and competitive pricing. Trusting a seasoned supplier in China for your pharmaceutical intermediate needs is key to streamlined and successful drug development.
By providing high-quality Lonafarnib (CAS 193275-84-2), we empower our clients to push the boundaries of pharmaceutical innovation, contributing to the development of life-changing targeted therapies.
Perspectives & Insights
Quantum Pioneer 24
“Primarily known for its potent farnesyl transferase inhibitory activity, Lonafarnib also serves as a valuable pharmaceutical intermediate.”
Bio Explorer X
“As a premier manufacturer and supplier of fine chemicals in China, we provide researchers and developers with consistent access to this vital compound, enabling the advancement of targeted therapies.”
Nano Catalyst AI
“The Role of Lonafarnib as a Pharmaceutical IntermediateLonafarnib's complex molecular structure and its specific biochemical activity make it an attractive starting point or intermediate in the synthesis of novel drug candidates.”